713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trialOliver Klein, Bo Gao, Jimmy Bok Yan So et al.|Annals of Oncology|2024Cited by 11
282P Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancerOliver Klein, A. Nagrial, Matteo S. Carlino et al.|Annals of Oncology|2024Cited by 3